Paoletti, M., Marcellusi, A., Yang, J. and Mennini, F. S. (2023) “Cost-effectiveness of IMI/CIL/REL for the treatment of carbapenem non-susceptible Gram-negative bacterial infections”, Global and Regional Health Technology Assessment, 10(1), pp. 18–28. doi: 10.33393/grhta.2023.2488.